Henry Schein Inc. (HSIC) intrinsic value & 10-year financials

Henry Schein Inc. (HSIC) has a Graham intrinsic value of $27.42 per share. At $86.38 on Oct 17, 2026, the stock trades 215% above that value. Over the last 10 fiscal years revenue grew 1.5% a year to $13.2B, with an average return on invested capital of 13.0%.

Graham intrinsic value
$27.42
Share price (Oct 17, 2026)
$86.38
Price vs Graham value
215% above
Market cap
$10.5B
Revenue (FY2025)
$13.2B
Revenue growth (10-yr CAGR)
1.5%
ROIC (10-yr avg)
13.0%
Free cash flow (FY2025)
$573.0M

HSIC 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $13.2B $398.0M $3.27 $573.0M 5.0% 9.4%
FY2024 $12.7B $390.0M $3.05 $700.0M 4.9% 8.7%
FY2023 $12.3B $416.0M $3.16 $353.0M 5.0% 9.6%
FY2022 $12.6B $538.0M $3.91 $506.0M 5.9% 13.4%
FY2021 $12.4B $631.2M $4.45 $630.6M 6.9% 17.2%
FY2020 $10.1B $403.8M $2.82 $550.1M 5.3% 12.4%
FY2019 $10.0B $694.7M $4.65 $577.9M 7.2% 15.8%
FY2018 $13.2B $535.9M $3.49 $594.1M 5.7% 15.7%
FY2017 $8.9B $406.3M $2.57 $464.0M 9.7% 12.8%
FY2016 $11.6B $506.8M $3.10 $572.4M 6.7% 15.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Henry Schein has demonstrated mature, steady growth, with revenue compounding at 1.5% annually over the past decade.

Henry Schein returns on capital have been average, hovering around 13.0% ROIC over the decade.

Over the decade, Henry Schein shows that management has aggressively returned capital to shareholders by retiring 25.7% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Henry Schein is modeled at 0.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $27.42 per share.

HSIC stock: frequently asked questions

What is the intrinsic value of Henry Schein Inc. (HSIC) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 0.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, HSIC's intrinsic value is about $27.42 per share.

Is HSIC stock undervalued?

At $86.38 (close on Oct 17, 2026), HSIC trades 215% above its Graham value of $27.42. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Henry Schein Inc. grown?

Revenue went from $11.6B in fiscal 2016 to $13.2B in fiscal 2025, a compound annual growth rate of 1.5%. Net income was $398.0M in fiscal 2025.

Does Henry Schein Inc. generate free cash flow?

Henry Schein Inc. generated $573.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is HSIC's return on invested capital?

Average ROIC over the last 10 fiscal years was 13.0%, and average return on equity was 15.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this HSIC data come from?

From Henry Schein Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 4, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar wholesale-medical, dental & hospital equipment & supplies stocks